She will serve on the company’s Audit Committee, a position that went into effect March 30. She has more than 20 years of experience as a healthcare executive and has overseen the revenue growth at AmSurg from $30 million to more than $1.62 billion.
Ms. Gulmi also helped orchestrate AmSurg’s Sheridan healthcare acquisition, valued at $2.35 billion.
Air Methods is an air medical transportation company.
More articles on healthcare:
Global mHealth market to see growth of 40% in 6 years—4 things to know
The Joint Commission proposes requirements for optional TJR certification program
Outlook for the ASC space: How to position for the next big opportunities
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
